Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.
Garcia-Loza I, Perna-Barrull D, Aguilera E, Almenara-Fuentes L, Gomez-Muñoz L, Greco D, Vila M, Salvado M, Mancera-Arteu M, Olszowy MW, Petriz J, Dalmases M, Rodriguez-Vidal S, Barneda-Zahonero B, Vives-Pi M.
Garcia-Loza I, et al. Among authors: salvado m.
J Autoimmun. 2024 May;145:103196. doi: 10.1016/j.jaut.2024.103196. Epub 2024 Mar 8.
J Autoimmun. 2024.
PMID: 38458075
Free article.